false 0001866838 0001866838 2024-05-14 2024-05-14 0001866838 IGTA:UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueonehalf12OfOneRedeemableWarrantAndOneRightEntitlingHolderToReceiveOnetenthOfShareOfCommonStockMember 2024-05-14 2024-05-14 0001866838 IGTA:CommonStockParValue0.0001PerShareMember 2024-05-14 2024-05-14 0001866838 IGTA:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member 2024-05-14 2024-05-14 0001866838 IGTA:RightsEachToReceiveOnetenthOfOneShareOfCommonStockMember 2024-05-14 2024-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 14, 2024

 

INCEPTION GROWTH ACQUISITION LIMITED

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41134   86-2648456
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

875 Washington Street
New York, NY
  10014
(Address of Principal Executive Offices)    (Zip Code)

 

Registrant’s telephone number, including area code: (315) 636-6638

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Units, each consisting of one share of common stock, $0.0001 par value, one-half (1/2) of one redeemable warrant and one right entitling the holder to receive one-tenth of a share of common stock   IGTAU   The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share   IGTA   The Nasdaq Stock Market LLC
Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50   IGTAW   The Nasdaq Stock Market LLC
Rights, each to receive one-tenth of one share of common stock   IGTAR   The Nasdaq Stock Market LLC

 

 

 

 

 

 

Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

In connection with the preparation of the financial statements for Inception Growth Acquisition Limited (the “Company”) as of and for the year ended December 31, 2023, the Company’s management, in consultation with its advisors  , identified two errors made in certain of the Company’s previously issued financial statements, arising from the manner in which the Company accounted for the deferred underwriting compensation in connection with the Company’s initial public offering and the classification of non-redemption agreement expenses. The Company previously overstated $337,500 deferred underwriting compensation  and classified the non-redemption agreement expenses as additional paid-in capital item. The Company’s management determined, after consultation with its advisors , that the deferred underwriting compensation should be decreased to the maximum allowed by the underwriting agreement, and the non-redemption agreement expenses should be reclassified as profit and loss item.

 

On May 14, 2024, the audit committee of the board of directors of the Company (the “Audit Committee”) determined, after discussion with its advisors , including Adeptus Partners, LLC, the Company’s independent accountant, that the Company’s (i) unaudited financial statements as of and for the quarter and nine months ended September 30, 2023 contained in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 14, 2023, (ii) unaudited financial statements as of and for the quarter and six months ended June 30, 2023 contained in the Company’s Quarterly Report on Form 10-Q filed on August 14, 2023, (iii) unaudited financial statements as of and for the quarter ended March 31, 2023 contained in the Company’s Quarterly Report on Form 10-Q filed on May 22, 2023, (iv) unaudited financial statements as of and for the quarter and nine months ended September 30, 2022 contained in the Company’s Quarterly Report on Form 10-Q filed on November 14, 2022, (v) unaudited financial statements as of and for the quarter and six months ended June 30, 2022 contained in the Company’s Quarterly Report on Form 10-Q filed on August 12, 2022, (vi) unaudited financial statements as of and for the quarter ended March 31, 2022 contained in the Company’s Quarterly Report on Form 10-Q filed on May 16, 2022 (the aforementioned Quarterly Reports from (i) through (vi), collectively, the “Prior 10-Qs”), should no longer be relied upon due to the errors described above.

 

As a result, the Company plans to amend the Prior 10-Qs to restate its unaudited financial statements as of and for the applicable reporting periods, which the Company intends to file as soon as practicable.

 

The Company does not expect the changes described above to have any impact on its cash position, revenues, liquidity, or the balance held in its trust account.

 

The Company’s management   has concluded that in light of the errors described above, a material weakness exists in the Company’s internal control over financial reporting and that the Company’s disclosure controls and procedures were not effective.

 

The Company’s management and the Audit Committee have discussed the matters disclosed in this Current Report on Form 8-K pursuant to this Item 4.02 with Adeptus Partners, LLC, the Company’s independent registered public accounting firm.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Inception Growth Acquisition Limited
     
Date: May 17, 2024 By: /s/ Cheuk Hang Chow
    Name:  Cheuk Hang Chow
    Title: Chief Executive Officer

 

2

 

v3.24.1.1.u2
Cover
May 14, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date May 14, 2024
Entity File Number 001-41134
Entity Registrant Name INCEPTION GROWTH ACQUISITION LIMITED
Entity Central Index Key 0001866838
Entity Tax Identification Number 86-2648456
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 875 Washington Street
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10014
City Area Code 315
Local Phone Number 636-6638
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Units, each consisting of one share of common stock, $0.0001 par value, one-half (1/2) of one redeemable warrant and one right entitling the holder to receive one-tenth of a share of common stock  
Title of 12(b) Security Units, each consisting of one share of common stock, $0.0001 par value
Trading Symbol IGTAU
Security Exchange Name NASDAQ
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol IGTA
Security Exchange Name NASDAQ
Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50  
Title of 12(b) Security Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50
Trading Symbol IGTAW
Security Exchange Name NASDAQ
Rights, each to receive one-tenth of one share of common stock  
Title of 12(b) Security Rights, each to receive one-tenth of one share of common stock
Trading Symbol IGTAR
Security Exchange Name NASDAQ

Inception Growth Acquisi... (NASDAQ:IGTAW)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Inception Growth Acquisi... 차트를 더 보려면 여기를 클릭.
Inception Growth Acquisi... (NASDAQ:IGTAW)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Inception Growth Acquisi... 차트를 더 보려면 여기를 클릭.